Ryan D. Morin

21.4k total citations · 3 hit papers
109 papers, 6.8k citations indexed

About

Ryan D. Morin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Ryan D. Morin has authored 109 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 50 papers in Pathology and Forensic Medicine and 36 papers in Cancer Research. Recurrent topics in Ryan D. Morin's work include Lymphoma Diagnosis and Treatment (46 papers), Cancer Genomics and Diagnostics (23 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Ryan D. Morin is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), Cancer Genomics and Diagnostics (23 papers) and Chronic Lymphocytic Leukemia Research (21 papers). Ryan D. Morin collaborates with scholars based in Canada, United States and United Kingdom. Ryan D. Morin's co-authors include Marco A. Marra, Martin Hirst, Yongjun Zhao, Helen McDonald, Florian Kuchenbauer, Randy D. Gascoyne, Thomas Zeng, Steven J.M. Jones, Allen Delaney and Miguel Alcaide and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Ryan D. Morin

101 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells

2008 874 citations Ryan D. Morin, Florian Kuchenbauer et al. profile →
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

2020 583 citations Ryan D. Morin, Jeffrey Tang et al. profile →
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

2009 507 citations Daniel T. Starczynowski, Florian Kuchenbauer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan D. Morin Canada	38	4.0k	2.4k	1.7k	1.3k	867	109	6.8k
Iñigo Martincorena United Kingdom	26	3.5k 0.9×	2.6k 1.1×	740 0.4×	1.2k 0.9×	276 0.3×	45	6.3k
Alison H. Banham United Kingdom	48	3.5k 0.9×	2.1k 0.9×	1.9k 1.1×	3.1k 2.5×	660 0.8×	147	10.5k
Sean Humphray United Kingdom	24	2.5k 0.6×	2.7k 1.1×	791 0.5×	1.4k 1.1×	246 0.3×	34	5.3k
Takao Sekiya Japan	35	3.9k 1.0×	1.1k 0.4×	891 0.5×	1.9k 1.5×	322 0.4×	129	7.1k
C M Croce United States	46	5.2k 1.3×	1.3k 0.5×	1.5k 0.9×	2.4k 1.9×	1.3k 1.5×	102	8.8k
Erik K. Flemington United States	51	4.2k 1.1×	2.1k 0.9×	976 0.6×	3.5k 2.8×	191 0.2×	157	8.0k
Hans G. Drexler Germany	43	4.2k 1.1×	913 0.4×	925 0.5×	1.5k 1.2×	1.0k 1.2×	249	7.7k
Alexander Dobrovic Australia	54	6.3k 1.6×	2.8k 1.1×	1.3k 0.8×	3.7k 2.9×	572 0.7×	219	10.8k
Dirk Eick Germany	57	8.9k 2.2×	991 0.4×	689 0.4×	2.6k 2.1×	273 0.3×	131	10.8k
Charles W.M. Roberts United States	46	9.0k 2.3×	1.3k 0.5×	3.3k 1.9×	1.4k 1.1×	277 0.3×	95	10.7k

Countries citing papers authored by Ryan D. Morin

Since Specialization

Citations

This map shows the geographic impact of Ryan D. Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan D. Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan D. Morin more than expected).

Fields of papers citing papers by Ryan D. Morin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan D. Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan D. Morin. The network helps show where Ryan D. Morin may publish in the future.

Co-authorship network of co-authors of Ryan D. Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan D. Morin. A scholar is included among the top collaborators of Ryan D. Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan D. Morin. Ryan D. Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Newby, Maddy L., Joel D. Allen, Giorgia Chiodin, et al.. (2025). The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma. Blood. 146(23). 2808–2820.

Yoshifuji, Kota, Yuki Saito, Mariko Tabata, et al.. (2025). In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis. Blood Advances. 9(19). 5040–5055.

Coyle, Krysta M., Matthew C. Cheung, Bruno M. Grande, et al.. (2022). Shared and distinct genetic features in human and canine B-cell lymphomas. Blood Advances. 6(11). 3404–3409. 5 indexed citations

Xia, Min, Liron David, Matt Teater, et al.. (2022). BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. Cancer Discovery. 12(8). OF1–OF20. 12 indexed citations

Speller, Camilla, et al.. (2021). DNA-based species identification of ancient salmonid remains provides new insight into pre-contact Coast Salish salmon fisheries in Burrard Inlet, British Columbia, Canada. Journal of Archaeological Science Reports. 37. 102956–102956. 7 indexed citations

Morin, Ryan D., Sarah E. Arthur, & Sarit Assouline. (2021). Treating lymphoma is now a bit EZ-er. Blood Advances. 5(8). 2256–2263. 20 indexed citations

Jiang, Aixiang, Laura K. Hilton, Jeffrey Tang, et al.. (2020). PRPS-ST: A Protocol-Agnostic Self-training Method for Gene Expression–Based Classification of Blood Cancers. Blood Cancer Discovery. 1(3). 244–257. 6 indexed citations

Mendis, Shehara, Miguel Alcaide, James T. Topham, et al.. (2020). Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer. Clinical Colorectal Cancer. 19(2). 132–136.e3. 1 indexed citations

Grande, Bruno M., et al.. (2019). SUBSTRA: Supervised Bayesian Patient Stratification. Bioinformatics. 35(18). 3263–3272. 4 indexed citations

10.

Shafaattalab, Sanam, Eric Lin, Francis C. Lynn, et al.. (2019). In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants. Proceedings of the National Academy of Sciences. 116(14). 6969–6974. 13 indexed citations

11.

Hilton, Laura K., Jeffrey Tang, Susana Ben‐Neriah, et al.. (2019). The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 134(18). 1528–1532. 76 indexed citations

12.

Albuquerque, Marco, Bruno M. Grande, Elie Ritch, et al.. (2017). Enhancing knowledge discovery from cancer genomics data with Galaxy. GigaScience. 6(5). 1–13. 5 indexed citations

13.

Taghiyar, M. Jafar, Jamie Rosner, Diljot Grewal, et al.. (2017). Kronos: a workflow assembler for genome analytics and informatics. GigaScience. 6(7). 1–10. 5 indexed citations

14.

Collinge, Brett, Lauren C. Chong, Susana Ben‐Neriah, et al.. (2017). Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism. Blood. 130. 3994–3994. 1 indexed citations

15.

Lowes, Lori E., Scott V. Bratman, Ryan Dittamore, et al.. (2016). Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation. International Journal of Molecular Sciences. 17(9). 1505–1505. 53 indexed citations

16.

Jensen, Victor L., Anna A. W. M. Sanders, Chunmei Li, et al.. (2016). Whole-Organism Developmental Expression Profiling Identifies RAB-28 as a Novel Ciliary GTPase Associated with the BBSome and Intraflagellar Transport. PLoS Genetics. 12(12). e1006469–e1006469. 48 indexed citations

17.

Nielsen, Julie S., Aniqa Shahid, Zusheng Zong, et al.. (2015). Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells. Clinical Cancer Research. 22(9). 2226–2236. 18 indexed citations

18.

Yakovenko, Oleksandr, et al.. (2013). Theoretical Investigation of the D83V Mutation within the Myocyte-Specific Enhancer Factor-2 Beta and Its Role in Cancer. 2013. 1–10. 3 indexed citations

19.

Starczynowski, Daniel T., Ryan D. Morin, Andrew McPherson, et al.. (2010). Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 117(2). 595–607. 94 indexed citations

20.

Dolgosheina, Elena V., Ryan D. Morin, Gozde Aksay, et al.. (2008). Conifers have a unique small RNA silencing signature. RNA. 14(8). 1508–1515. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact